Status:
UNKNOWN
Can Undetectable (Viral Load) = Untransmissible (Virus) Change the Life Course of Adolescents Living in Africa
Lead Sponsor:
Centre for Sexual Health and HIV/AIDS Research Zimbabwe
Collaborating Sponsors:
European and Developing Countries Clinical Trials Partnership (EDCTP)
Conditions:
HIV/AIDS
Eligibility:
All Genders
13-19 years
Brief Summary
The scientific breakthrough related to Undetectable (viral load) = Untransmissible (virus) has had a major impact on motivation to take up and adhere to antiretroviral therapy among people living with...
Detailed Description
Rationale: Adolescents living with HIV (ALHIV) have the worst outcomes of all ages because of sub-optimal adherence driven by structural factors associated with poverty. This is exacerbated for adoles...
Eligibility Criteria
Inclusion
- ALHIV aged 13-19 years who are aware of their HIV status for at least six months before enrolment (i.e., know the infection by its name and understand some of its implications).
- ART initiation of not less than 6 months.
- ALHIV accessing ART within the participating clinics.
- Healthcare workers with direct contact with ALHIV and have been involved in viral load result counselling in participating clinics.
Exclusion
- Unable to provide informed assent/ and parental informed consent.
- Requires urgent medical attention or has severe mental health problems that would invalidate the informed assent/consent process or else contraindicate participation.
Key Trial Info
Start Date :
March 24 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2024
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05278559
Start Date
March 24 2022
End Date
June 1 2024
Last Update
September 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beatrice Road Infectious Hospital
Harare, Zimbabwe, 00000